NPM1 and acute myeloid leukemia: Pediatric studies demonstrate a higher EFS and OS with NPM1 mutations, particularly in cytogenetically normal AML or when they occur in the context of HR mutations where the presence of mutated NPM1 may improve outcomes compared to the HR genetic feature alone [5, 6, 10••].